Matteo Mancino

Dr. Matteo Mancino

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2025 in European Journal of Radiology
Verified
Journal Article
Open access
FGFabio De Giorgio
Fabio De Giorgio
BBBeatrice Benedetti
Beatrice Benedetti
Matteo MancinoMatteo Mancino
Matteo Mancino
ESEvis Sala
Evis Sala
VPVincenzo L. Pascali
Vincenzo L. Pascali
Radiology is one of the medical specialties most significantly impacted by Artificial Intelligence (AI). AI systems, particularly those employing machine and deep learning, excel in processing large datasets and comparing images from similar contexts, fulfilling radiological demands. However, the implementation of AI in radiology presents notable challenges, including concerns about data privacy, informed consent, and the potential for external interferences affecting decision-making processes. Biases represent another critical issue, often stemming from unrepresentative datasets or inadequate system training, which can lead to distorted outcomes and exacerbate healthcare inequalities. Additionally, generative AI systems may produce 'hallucinations' arising from their reliance on probabilistic modeling without the ability to distinguish between true and false information. Such risks raise ethical and legal questions, especially when AI-induced errors harm patient health. Concerning liability for medical errors involving AI, healthcare professionals currently retain full accountability for their decisions. AI systems remain tools to support, not replace, human expertise and judgment. Nevertheless, the "black box" nature of many AI models - wherein the reasoning behind outputs remains opaque - limits the possibility of fully informed consent. We advocate for prioritizing Explainable Artificial Intelligence (XAI) in radiology. While potentially less performant than black-box models, XAI enhances transparency, allowing patients to understand how their data is used and how AI influences clinical decisions, aligning with ethical standards.

15 November 2024 in European Journal of Surgical Oncology
Verified
Journal Article
Open access
LBLuca Boldrini
Luca Boldrini
DCDiepriye Charles-Davies
Diepriye Charles-Davies
ARAngela Romano
Angela Romano
Matteo MancinoMatteo Mancino
Matteo Mancino
INIlaria Nacci
Ilaria Nacci
GCGiuditta Chiloiro
Giuditta Chiloiro
Predicting pathological complete response (pCR) from pre or post-treatment features could be significant in improving the process of making clinical decisions and providing a more personalized treatment approach for better treatment outcomes. However, the lack of external validation of predictive models, missing in several published articles, is a major issue that can potentially limit the reliability and applicability of predictive models in clinical settings. Therefore, this systematic review described different externally validated methods of predicting response to neoadjuvant chemoradiotherapy (nCRT) in locally advanced rectal cancer (LARC) patients and how they could improve clinical decision-making. An extensive search for eligible articles was performed on PubMed, Cochrane, and Scopus between 2018 and 2023, using the keywords: (Response OR outcome) prediction AND (neoadjuvant OR chemoradiotherapy) treatment in 'locally advanced Rectal Cancer'. (i) Studies including patients diagnosed with LARC (T3/4 and N- or any T and N+) by pre-medical imaging and pathological examination or as stated by the author (ii) Standardized nCRT completed. (iii) Treatment with long or short course radiotherapy. (iv) Studies reporting on the prediction of response to nCRT with pathological complete response (pCR) as the primary outcome. (v) Studies reporting external validation results for response prediction. (vi) Regarding language restrictions, only articles in English were accepted. (i) We excluded case report studies, conference abstracts, reviews, studies reporting patients with distant metastases at diagnosis. (ii) Studies reporting response prediction with only internally validated approaches. Three researchers (DC-D, FB, HT) independently reviewed and screened titles and abstracts of all articles retrieved after de-duplication. Possible disagreements were resolved through discussion among the three researchers. If necessary, three other researchers (LB, GC, MG) were consulted to make the final decision. The extraction of data was performed using the CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies (CHARMS) template and quality assessment was done using the Prediction model Risk Of Bias Assessment Tool (PROBAST). A total of 4547 records were identified from the three databases. After excluding 392 duplicate results, 4155 records underwent title and abstract screening. Three thousand and eight hundred articles were excluded after title and abstract screening and 355 articles were retrieved. Out of the 355 retrieved articles, 51 studies were assessed for eligibility. Nineteen reports were then excluded due to lack of reports on external validation, while 4 were excluded due to lack of evaluation of pCR as the primary outcome. Only Twenty-eight articles were eligible and included in this systematic review. In terms of quality assessment, 89 % of the models had low concerns in the participants domain, while 11 % had an unclear rating. 96 % of the models were of low concern in both the predictors and outcome domains. The overall rating showed high applicability potential of the models with 82 % showing low concern, while 18 % were deemed unclear. Most of the external validated techniques showed promising performances and the potential to be applied in clinical settings, which is a crucial step towards evidence-based medicine. However, more studies focused on the external validations of these models in larger cohorts is necessary to ensure that they can reliably predict outcomes in diverse populations.

7 December 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
ADAnna D'Angelo
Anna D'Angelo
APAntonio Portaluri
Antonio Portaluri
FCFlavia Caprini
Flavia Caprini
CSCarmelo Sofia
Carmelo Sofia
FFFrancesca Ferrara
Francesca Ferrara
MMMaria Adele Marino
Maria Adele Marino
Pathological conditions affecting the male breast (MB) share some similarities with those found in women, while others are specific to men. The first part of this review provides an overview of MB disorders, exploring the most common types of MB diseases. The second part then emphasizes the state-of-the-art approaches proposed in the literature for screening and follow-up with MB cancer patients, which highlights the importance of tailored strategies for diagnosis, follow-up, and identifying high-risk populations. Considering the increasing attention in recent years on the topic, transgender individuals are also included in this review. Together with the MB, it is an understudied category thus far. This review aims to raise awareness among radiologists that MBs should be approached differently from female breasts, contributing to the advancement of medical knowledge, improving patient outcomes, and promoting early detection of MB disorders. The review also provides an update on breast cancer and screening in the transgender population.

26 February 2025 in European Journal of Radiology
Verified
Journal Article
Open access
FGFabio De Giorgio
Fabio De Giorgio
BBBeatrice Benedetti
Beatrice Benedetti
Matteo MancinoMatteo Mancino
Matteo Mancino
ESEvis Sala
Evis Sala
VPVincenzo L. Pascali
Vincenzo L. Pascali
In recent years, post-mortem imaging has advanced with techniques such as Post-Mortem Computed Tomography (PMCT) and Post-Mortem Magnetic Resonance imaging (PMMR). PMCT is particularly useful for assessing skeletal injuries, vascular lesions, and estimating post-mortem intervals. These analyses are based on radiomics principles, a growing field that requires specialized expertise, which is still limited. To support this field, post-mortem imaging biobanks are proposed as valuable tools, especially when enhanced with Artificial Intelligence (AI). However, complexities in this field require caution and adherence to guidelines, especially regarding consent for image storage, participant information, international cooperation, and nonprofit operations.

20 December 2024 in International journal of legal medicine
Verified
Journal Article
Closed access
PDF file
FGFabio De Giorgio
Fabio De Giorgio
MGMichele Guerreri
Michele Guerreri
RGRoberto Gatta
Roberto Gatta
EBEva Bergamin
Eva Bergamin
VVVittorio De Vita
Vittorio De Vita
VPVincenzo L. Pascali
Vincenzo L. Pascali

6 January 2025 in European Journal of Radiology
Verified
Journal Article
Open access
CGConsolato Gullì
Consolato Gullì
LRLuca Russo
Luca Russo
DGDiana Gavrila
Diana Gavrila
MMMatteo Mangialardi
Matteo Mangialardi
GMGiorgio Mazzotta
Giorgio Mazzotta
BGBenedetta Gui
Benedetta Gui
To assess the incidence of pelvic insufficiency fractures (PIFs) after concurrent chemoradiotherapy (CCRT) in patients with locally advanced cervical cancer (LACC), their time of onset and risk factors. We also analysed the inter-observer agreement between gynaecologic radiologists (GYN readers) and radiologists expert in musculoskeletal imaging (MSK reader) in detecting PIFs in our tertiary care centre. Patients with confirmed LACC who underwent concurrent chemoradiation (CCRT) at our institution from June 2019 to November 2022 were retrospectively included. These patients underwent follow-up pelvic MRI every 3-6 months after CCRT. Cohen's kappa statistics was employed to assess the inter-observer agreement between GYN and MSK readers.Logistic regression analysis was performed calculating odds ratios (OR) to identify risk factors for PIFs, such as age, body mass index (BMI), diabetes, smoking, hypertension, renal function and tumour size. Eighty-seven patients were included. PIFs were diagnosed in 21/87 (24.1 %) patients with a median onset time of 7.4 months from the end of EBRT. Among risk factors, age was statistically associated with PIFs (OR = 1.057, 95 % CI: 1.005-1.118, p = 0.033) with median age in the fracture group of 61.1 years (range: 52.0-71.5) and 53.8 years (range: 43.8-63.3). BMI was a significant predictor of PIFs (OR = 1.134; 95 % CI: 1.013-1.285; p = 0.027), with a higher median BMI among patients with PIFs (26.5; range: 21.5-31.2) compared to non-fractured patients (23.1; range: 20.2-25.1). Also patients with reduced renal function (eGFR < 60 mL/min) had 3.437 times higher odds of experiencing fractures compared to those with normal eGFR. The GYN readers correctly identified PIFs in 2/21 cases and agreed with the MSK reader in 68/87 cases. The interobserver agreement was poor to fair (K = 0.138; 95 % CI: 0-0.311). PIFs are a common complication of CCRT. Their identification on post-CCRT MRI may decrease the need for further targeted investigations and invasive treatments.